Search

Search Constraints

You searched for: Author/Creator Pizzuti, Laura

Search Results

1. A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study. Issue 2 (1st February 2019)

2. A Real‐World Multicentre Retrospective Study of Paclitaxel‐Bevacizumab and Maintenance Therapy as First‐Line for HER2‐Negative Metastatic Breast Cancer. Issue 6 (30th November 2016)

3. Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment. (2nd June 2016)

5. Anthropometric, Metabolic and Molecular Determinants of Human Epidermal Growth Factor Receptor 2 Expression in Luminal B Breast Cancer. Issue 8 (August 2015)

6. Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer. Issue 8 (3rd March 2017)

7. Body mass index and treatment outcomes following neoadjuvant therapy in women aged 45 y or younger: Evidence from a historic cohort. Issue 5 (3rd May 2016)

8. Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin. Issue 5 (20th November 2015)

9. Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab. Issue 4 (3rd April 2018)

10. Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer. Issue 1 (December 2017)